Log in to save to my catalogue

Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease

Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6351226

Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease

About this item

Full title

Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Nature nanotechnology, 2018-09, Vol.13 (9), p.812-818

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Graphene quantum dots inhibit the formation of alpha-synuclein fibrils and induce their dissociation in vitro, and display neuro-protective properties in in vivo models of Parkinson’s disease, with no appreciable long-term toxicity.
Though emerging evidence indicates that the pathogenesis of Parkinson’s disease is strongly correlated to the accu...

Alternative Titles

Full title

Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6351226

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6351226

Other Identifiers

ISSN

1748-3387

E-ISSN

1748-3395

DOI

10.1038/s41565-018-0179-y

How to access this item